Overview
Scabies, a highly contagious skin infestation caused by the Sarcoptes scabiei mite, is seeing a troubling resurgence—particularly among urban homeless populations. Even more concerning is the rise of drug-resistant scabies, where standard treatments such as permethrin and ivermectin are becoming less effective. Overcrowding, lack of hygiene access, and treatment delays are accelerating the spread and mutation of this skin disease.
What Is Scabies?
Scabies is a parasitic skin condition where microscopic mites burrow into the skin, causing intense itching, rashes, and secondary infections. It spreads through prolonged skin-to-skin contact and through shared clothing or bedding.
Why Drug Resistance Is Emerging
- Frequent Reinfestation: In homeless communities, reinfection is common due to shared spaces and lack of follow-up care.
- Incorrect or Incomplete Treatment: Partial use of topical agents or misuse of oral medications encourages mite survival and resistance development.
- Overuse of Permethrin and Ivermectin: Repeated exposure without eradication contributes to drug-resistant mite strains.
- Poor Access to Healthcare: Delays in diagnosis and inconsistent treatment make full eradication difficult, enabling mutation and spread.
Populations Most at Risk
- Homeless individuals living in shelters or encampments
- Migrant and refugee groups in crowded housing
- People with compromised immune systems
- Children in high-density daycare environments (secondary spread)
Symptoms of Drug-Resistant Scabies
- Persistent itching that does not improve with standard treatment
- Crusted (Norwegian) scabies: thick, scaly skin teeming with mites
- Lesions on hands, feet, waistline, genitals, and underarms
- Secondary bacterial infections (e.g., impetigo, cellulitis)
Diagnosis
- Clinical skin examination
- Skin scrapings observed under a microscope to identify mites or eggs
- Dermoscopy for visual confirmation
- PCR testing in advanced clinical settings to detect resistant strains
Treatment Challenges
- Ineffective Permethrin Cream (5%): Once the first-line treatment, increasingly showing reduced efficacy
- Oral Ivermectin: Used alone or in combination, but resistance is being documented
- Combined Therapies: Dual therapy (permethrin + ivermectin) may be needed for resistant cases
- Crusted Scabies: Often requires hospitalization, multiple treatments, and decontamination of belongings
Prevention and Control
- Improve hygiene facilities in shelters and encampments
- Routine screening and mass treatment in outbreak areas
- Education on proper use of topical and oral treatments
- Provide clean clothing and bedding
- Develop new anti-parasitic agents or vaccines under clinical research
Public Health Impact
Drug-resistant scabies is becoming a neglected urban health threat. Its spread not only affects vulnerable populations but can also lead to outbreaks in schools, hospitals, and care homes. Tackling it requires an integrated public health response involving housing, dermatology, and infectious disease specialists.